Search

Your search keyword '"de Ledinghen, V."' showing total 587 results

Search Constraints

Start Over You searched for: Author "de Ledinghen, V." Remove constraint Author: "de Ledinghen, V."
587 results on '"de Ledinghen, V."'

Search Results

1. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

2. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

4. A global research priority agenda to advance public health responses to fatty liver disease

5. The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and territories

6. Global multi-stakeholder endorsement of the MAFLD definition

7. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease

8. Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset

9. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

10. The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease.

11. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

12. A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients

14. Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection

15. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study

17. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study

18. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

20. Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

21. Advancing the global public health agenda for NAFLD: a consensus statement

22. Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis: a mediation analysis

23. OC-06A cholestatic pattern predicts liver-related events in patients with nonalcoholic fatty liver disease

24. OC-10Liver-related and extrahepatic events occurrence in patients with nonalcoholic fatty liver disease: a competing risk analysis

26. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis

27. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

28. Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring

32. T06.01.19 THE ECONOMIC COST AND HEALTH BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIES

34. The economic cost and health burden of non-alcoholic steatohepatitis (NASH) in the EU5 countries

36. Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease

39. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

49. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study

50. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

Catalog

Books, media, physical & digital resources